Clinical Trial Detail

NCT ID NCT02188264
Title Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

Advanced Solid Tumor

Therapies

Cyclosporine

Selumetinib

Age Groups: adult

No variant requirements are available.